The global breast cancer diagnostics market is expected to reach USD 8.4 billion by 2026, expanding at a 7.7.% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Factors such as growing incidence of breast cancer and increasing healthcare spending and research activities are projected to drive the growth.
Breast
cancer is the leading cause of cancer-related death among women and is the most
common type of cancer overall. As per the World Cancer Research Fund (WCRF)
International, around 2 million new breast cancer cases were recorded globally
in 2018. According to Breastcancer.org, in U.S., around one in every women will
be diagnosed with invasive breast cancer during her lifetime. It is projected
that around 268,600 new cases of invasive breast cancer will be detected in
U.S., in 2019.
Healthcare
organizations and governments are striving to raise awareness regarding early
diagnosis of the disease, through various independent and collaborative
initiatives. Furthermore, research entities, along with private and public
organizations, are heavily investing in research projects to develop advanced
breast cancer diagnostics, which can diagnose the disease even before the
symptoms appear.
Based
on type, the imaging segment accounted for the largest share of the breast
cancer diagnostics market in 2018 due to the increasing prevalence of the
disease. Availability of various imaging methods such as breast MRI,
ultrasonography, diagnostic mammography, and screening mammography is
anticipated to bode well for the growth. These tests enable quick and accurate
diagnosis. In addition, owing to the new technologically advanced techniques such
as contrast-enhanced digital mammography, the segment is expected to maintain
its dominance over the forecast period. The new techniques can detect the
disease a little earlier by revealing growth of the blood vessels related to
the tumor.
Full Research Report On Breast Cancer Diagnostics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/breast-cancer-diagnostics-market
Further key
findings from the report suggest:
- The blood
test is expected to be the fastest growing segment over the forecast
period owing to the launch of new blood tests. For instance, The
Heidelberg University Hospital in Germany introduced a test that can
detect breast tumor quickly and noninvasively using biomarkers in the
blood
- North America
was the largest revenue generating region in 2018 followed by Europe. High
R&D activities, well-established diagnostic infrastructure, patient
awareness, and presence of key players are some of the factor attributed
to their continued dominance
- Asia Pacific
is expected to witness the fastest CAGR during the forecast period owing
to the presence of large population base, target population, and high
unmet clinical needs
- Few major
players operating in the breast cancer diagnostics market are Myriad
Genetics, Inc.; Genomic Health; Hologic Inc.; NanoString Technologies,
Inc.; Danaher; Koninklijke Philips N.V.; Becton, Dickinson and Company;
Devicor Medical Products Inc.; and C.R. Bard, Inc.
- The key
players are adopting different strategies such as product development,
collaborations, and geographic expansion to increase their market share.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/breast-cancer-diagnostics-market/request/rs1
Grand View Research has
segmented the global breast cancer diagnostics market based on type and region:
Breast Cancer
Diagnostics Type Outlook (Revenue, USD Million, 2015 - 2026)
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
Breast Cancer
Diagnostics Regional Outlook (Revenue, USD Million, 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Colombia
- Chile
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment